Trial Profile
A Randomized, Double-blind, Placebo-controlled, Phase I Clinical Trial to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 After Oral Administration in Healthy Adult Volunteers : Part I- Single Dosing / Part II- Multiple Dosing
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Rocacetrapib (Primary)
- Indications Dyslipidaemias
- Focus Pharmacokinetics
- Sponsors Chong Kun Dang
- 11 Jul 2017 New trial record